http://orcid.org/0000-0002-2240-5768
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Deborah S. Finnell, Victoria Soltis-Jarrett, Jeffrey Bratberg, Andrew Muzyk, Yifei Liu, Ellen Edens, J. Paul Seale, Jill Mattingly, Kristen Schnurman, Victoria Osborne-Leute, Allen Zweben, Ann Cary & Brent A. Moore. (2022) Substance use–related continuing education course objectives: Alignment with professional competencies. Substance Abuse 43:1, pages 1363-1369.
Read now
Read now
John Magel, David Kietrys, Eric S. Kruger, Julie M. Fritz & Adam J. Gordon. (2021) Physical therapists should play a greater role in managing patients with opioid use and opioid misuse. Substance Abuse 42:3, pages 255-260.
Read now
Read now
Gerald Cochran, Julie Bruneau, Nicholas Cox & Adam J. Gordon. (2020) Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse 41:3, pages 269-274.
Read now
Read now
Beth A. Rutkowski. (2019) Specific disciplines addressing substance use: AMERSA in the 21st century. Substance Abuse 40:4, pages 392-395.
Read now
Read now
Articles from other publishers (16)
Jennie B. Jarrett, Jeffrey Bratberg, Anne L. BurnsGerald Cochran, Bethany A. DiPaula, Anna Legreid Dopp, Abigail Elmes, Traci C. Green, Lucas G. Hill, Felicity Homsted, Stephanie L. Hsia, Michele L. Matthews, Udi E. Ghitza, Li-Tzy Wu & Gavin Bart. (2023) Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy. Substance Abuse.
Crossref
Crossref
Molly A. Nichols, Elizabeth G. Riley, Alexander S. Chao, Carmina G. Sales, Monica L. Miller, Geoffrey M. Curran, Carol A. Ott, Margie E. Snyder & Karen Suchanek Hudmon. (2023) Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs. American Journal of Pharmaceutical Education 87:6, pages 100061.
Crossref
Crossref
Jeffrey P. Bratberg & Alyssa Falleni. (2023) Preserving dignity through expanded and sustained access to buprenorphine. Journal of the American Pharmacists Association 63:1, pages 220-223.
Crossref
Crossref
Anthony S. Floyd, Joseph Silcox, Emma Cousin, Adriane N. Irwin, Mary Gray, Derek Bolivar, Jeffrey Bratberg, Jenny Arnold, Zain Al-jammali, Ryan N. Hansen, Daniel M. Hartung & Traci C. Green. (2023) Readiness of community pharmacies to implement an opioid safety intervention. Journal of the American Pharmacists Association 63:1, pages 275-283.e1.
Crossref
Crossref
Kunle Rotimi, Favour K. Edeh, Jimmy Aiden, Ademola Joshua Itiola & Kehinde Obamiro. (2022) Factors that influence pharmacists' efforts in addressing substance use in Nigeria: An exploratory study. Exploratory Research in Clinical and Social Pharmacy 8, pages 100189.
Crossref
Crossref
Lucas Kosobuski, Andrew Hawn, Katelyn France, Nathaniel Chen, Cierra LaPlante & Laura Palombi. (2022) Using qualitative, community-based input to steer post–coronavirus disease 2019 pharmacy practice in substance use. Journal of the American Pharmacists Association 62:5, pages 1555-1563.e2.
Crossref
Crossref
Thomasine L. Heitkamp & LaVonne F. Fox. (2022) Addressing Disparities for Persons With Substance Use Disorders in Rural Communities. Journal of Addictions Nursing 33:3, pages 191-197.
Crossref
Crossref
Haley Pals & Jeffrey Bratberg. (2022) Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder. Journal of the American Pharmacists Association 62:4, pages 1422-1429.
Crossref
Crossref
Sarah Fatani, Daniel Bakke, Katelyn Halpape, Marcel D’Eon & Anas El-Aneed. (2022) Development and validation of patient-community pharmacist encounter toolkit regarding substance misuse: Delphi procedure. Journal of the American Pharmacists Association 62:1, pages 176-186.
Crossref
Crossref
Elizabeth Chiarello. (2021) Pharmacists should treat patients who have opioid use disorders, not police them. Journal of the American Pharmacists Association 61:6, pages e14-e19.
Crossref
Crossref
Li‐Tzy Wu, William S. John, Udi E. Ghitza, Aimee Wahle, Abigail G. Matthews, Mitra Lewis, Brett Hart, Zach Hubbard, Lynn A. Bowlby, Lawrence H. Greenblatt & Paolo Mannelli. (2021) Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network. Addiction 116:7, pages 1805-1816.
Crossref
Crossref
Neda J. Kazerouni, Adriane N. Irwin, Ximena A. Levander, Jonah Geddes, Kirbee Johnston, Carly J. Gostanian, Baylee S. Mayfield, Brandon T. Montgomery, Diana C. Graalum & Daniel M. Hartung. (2021) Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden. Drug and Alcohol Dependence 224, pages 108729.
Crossref
Crossref
Alyssa M Peckham, Jennifer Ball, Michelle D Colvard, David Dadiomov, Lucas G Hill, Stephanie D Nichols, Kimberly Tallian, Daniel J Ventricelli & Tran H Tran. (2021) Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic. American Journal of Health-System Pharmacy 78:7, pages 613-618.
Crossref
Crossref
Scott A. Coon, Lucas G. Hill, Robert W. Hutchison, Lindsay M. Arnold, Jennie B. Jarrett, Anne R. Ottney, Alvin B. Oung, Nathan A. Painter, Michael A. Smith, Paul M. Stranges, Tran H. Tran, Amanda R. McFee Winans & Jeffrey P. Bratberg. (2020) Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 3:8, pages 1493-1513.
Crossref
Crossref
Tran Tran, Jennifer Ball, Jeffrey P. Bratberg, Edward M. DeSimone, Thomas S. Franko, Lucas G. Hill, Cynthia P. Koh-Knox Sharp, Laura Palombi, Daniel Ventricelli, Dorothy Farrell, Nidhi Gandhi & Terri Moore. (2020) Report of the 2020 Special Committee on Substance Use and Pharmacy Education. American Journal of Pharmaceutical Education 84:11, pages 8421.
Crossref
Crossref
Heidi Eukel, Jayme Steig, Oliver Frenzel, Elizabeth Skoy, Amy Werremeyer & Mark Strand. (2020) Opioid Misuse and Overdose: Changes in Pharmacist Practices and Outcomes. Journal of Continuing Education in the Health Professions 40:4, pages 242-247.
Crossref
Crossref